Customized services to meet your needs.
35+ languages
Our team of specialists is proficiently trained in AE and PQC reporting while also providing exceptional levels of service.
Experience with Community Management Services across the globe. Complying with various regulatory bodies.
Facebook, Instagram, LinkedIn, X, and more.
ProPharma diligently oversees our clients' social media channels, monitoring for any emerging Adverse Events or Product Complaints. Whenever we spot something reportable, we promptly document and report our findings within the required timeframe, ensuring that critical information is not missed.
ProPharma actively engages with consumer comments and inquiries across various social media platforms acting as the client. We utilize a client-approved standard response document tailored specifically for these interactions. Whether responding publicly to comments beneath posts or privately through direct messages, ProPharma ensures that each interaction is professional, appropriate, and non-promotional. With this service, ProPharma will also remove inappropriate comments from your posts to keep your company’s image professional.
We are dedicated to enhancing the health and well-being of consumers through our comprehensive Community Management services. Whether you need reliable Social Media Monitoring Services or full service including Social Response Management, our team of experts is here to help.
October 21, 2026
Recent FDA enforcement activity is changing how MLR teams assess promotional risk. Learn why organizations are moving from defensible claims to predictive, enforcement-informed risk assessment.
October 19, 2026
Unlock AI success by understanding your data. Learn the foundations of AI readiness and how to build trust in your data for reliable insights.
October 13, 2026
Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.
July 8, 2026
ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.
June 18, 2026
ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.
January 27, 2026
ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.
-1.png?width=320&height=185&name=6%20-%20Medical%20Information%20%20(650%20x%20425%20px)-1.png)
.png?width=320&height=185&name=7%20-%20FSP%20Solutions%20%20(650%20x%20425%20px).png)
.png?width=320&height=185&name=_5%20-%20Pharmacovigilance%20Solutions%20(650%20x%20425%20px).png)